The Role of Mohs Surgery in Treating Squamous Cell Carcinoma: Evidence-Based Guidance for Providers

At Tri-Valley Dermatology in Murrieta and Hemet, CA, providers and patients alike often seek advanced solutions for squamous cell carcinoma (SCC), a common form of skin cancer. While many cases respond well to conventional treatment, complex or high-risk lesions benefit from Mohs micrographic surgery, a precise, tissue-sparing procedure that maximizes cancer removal while minimizing damage to healthy skin. Understanding its role, indications, and evidence-based benefits is essential for providers guiding patient care.

Understanding Squamous Cell Carcinoma and Its Challenges

Squamous cell carcinoma originates in the epidermal keratinocytes and can appear as scaly, red patches, nodules, or non-healing sores, often in sun-exposed areas such as the face, ears, or hands. While SCC is generally less aggressive than melanoma, untreated or advanced lesions can invade surrounding tissue and, in rare cases, metastasize. Complex or recurrent SCC presents challenges, particularly when lesions are located near critical structures, making precise excision essential for optimal outcomes.

Early recognition and accurate diagnosis by dermatologists or primary providers are vital. Timely referral for Mohs surgery allows for complete evaluation and treatment while minimizing scarring and preserving function, particularly in cosmetically sensitive areas.

Mohs Surgery: Precision and Preservation

Mohs surgery involves the meticulous removal of skin cancer layer by layer, with each layer examined under a microscope immediately after excision. This method ensures that all cancerous cells are removed while preserving as much healthy tissue as possible. The iterative process continues until no cancerous cells remain, reducing the risk of recurrence and improving overall cosmetic and functional outcomes.
This technique is particularly valuable for high-risk SCC, recurrent lesions, or tumors located in areas where tissue preservation is critical, such as the nose, lips, or ears. Evidence-based studies demonstrate that Mohs surgery offers the highest cure rates compared with standard excision, especially for aggressive or infiltrative tumors.

Provider Guidance and Patient Education

Providers play a crucial role in identifying candidates for Mohs surgery and educating patients about the procedure, recovery, and expected outcomes. Pre-operative evaluation includes reviewing medical history, assessing lesion size and location, and discussing potential benefits and risks. Post-operative care focuses on wound management, infection prevention, and monitoring for recurrence.

Collaboration between providers and dermatologic surgeons ensures that patients receive individualized, evidence-based care tailored to the complexity of their condition. This integrated approach enhances healing, supports functional preservation, and optimizes long-term outcomes.

For providers and patients seeking expert evaluation and treatment of squamous cell carcinoma, Tri-Valley Dermatology in Murrieta and Hemet, CA, offers advanced Mohs surgery, thorough guidance, and evidence-based care. To schedule an appointment and discuss treatment options, call 951-658-9461 today.